Join us for an interactive live symposium discussing the use of finerenone in patients with type 2 diabetes and chronic kidney disease. Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP and Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP will provide expert insights on the evidence behind the use of finerenone in diabetic kidney disease, selecting appropriate patients for finerenone therapy, and strategies for overcoming clinical inertia.
ProCE is committed to providing a safe and healthy environment for all our learners. Our decisions and preventive measures are guided by the requirements and recommendations of the CDC alongside federal, state, and local health authorities. We work with each program venue to implement preventive measures to reduce the potential spread of COVID-19. Additionally, in accordance with APhA’s COVID-19 protocols, all in-person learners will be asked to wear a mask and present their APhA conference badge -OR- proof of vaccination AND Government issued ID to gain admittance to Understanding the Role of Mineralocorticoid Receptor Antagonists and the Impact on Patient Care in Chronic Kidney Disease in Type 2 Diabetes and/or Digital Technologies in Diabetes Management: Considerations for Delivering State-of-the-Art Care.
For more information on APhA’s vaccination and mask requirements, please visit: https://aphameeting.pharmacist.com/aaStatic.asp?SFP=WkpaSkJNQkdAOTI4Ng
*If you do not have your vaccination record card, find out other ways to verify you have been vaccinated.
There are no upcoming events, please check back soon.